Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "US Acute Care Solutions" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about US Acute Care Solutions for you to read. Along with our medical data and news we also list US Acute Care Solutions Clinical Trials, which are updated daily. BioPortfolio also has a large database of US Acute Care Solutions Companies for you to search.
Partnership brings together Vifor Pharma’s world-class iron deficiency portfolio with Fresenius Kabi’s market-leading patient access in China Gives Vifor Pharma access to largest iron deficiency anaemia population with prevalence estimated at 20%1 Focus of the partnership will be on Patient Blood Management (PBM) to benefit both patients and the healthcare system in China Vifor Pharma ...
- Liposomal Cyclosporine A for Inhalation (L‑CsA‑i) is advancing in clinical studies for the treatment for bronchiolitis obliterans syndrome (BOS) - BOS is a devastating rare lung disease associated with high mortality - An estimated 30,000 lung transplant and allogeneic hematopoietic stem cell transplant (alloHSCT) recipients worldwide are affected by BOS1 - BOSTON-1 and BOSTON-2 are p...
Since December, 2019, an outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious epidemic in China and other countries, resulting in worldwide concern.1 Family clusters of infected individuals have been reported, and this phenomenon could present a serious threat to public health if not strictly controlled. In a previo...
In view of the global increase in multidrug-resistant bacteria, applying contact precautions during the care of affected patients seems, at first, a rational approach to decrease the spread of these organisms. Increasing the distance between sources of multidrug-resistant organisms and potential recipients and using disposable equipment, such as gloves and gowns, for any contact with the patient a...
[Articles] Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial
Contact isolation showed no benefit when added to standard precautions for controlling the spread of ESBL-E on non-critical care wards with extensive surveillance screening.
In December, 2019, a local outbreak of pneumonia of initially unknown cause was detected in Wuhan (Hubei, China), and was quickly determined to be caused by a novel coronavirus,1 namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak has since spread to every province of mainland China as well as 27 other countries and regions, with more than 70 000 confirmed cases as ...
European regulators released a proposal for regulating artificial intelligence that calls for strict enforcement of ethical and technical standards to protect the rights of consumers in safety-critical industries such as health care. https://buff.ly/39N6f
European regulators released a proposal for regulating artificial intelligence that calls for strict enforcement of ethical and technical standards to protect the rights of consumers in safety-critical industries such as health care. https://buff.ly/39N6fiV
California Gov. Gavin Newsom dedicated nearly all of his State of the State address Wednesday to homelessness. To fix that problem, he said, the state must address another one: mental health care.
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common stock at a price to the public of $28.00 per share. The gross proceeds of the offering to Twist before deducting the underwriting discount...
Researchers from The Johns Hopkins Center for Fetal Therapy report new evidence that fetuses with severe congenital diaphragmatic hernia, a rare but life-threatening, lung-damaging condition, experience a significantly high rate of success for the fetal treatment known as FETO, if they and their mothers receive coordinated and highly experienced care in the same expert setting.
Nearly 40% of acute trusts in England do not offer any non-pharmacological therapies to help manage symptoms such as distress, aggression and agitation in patients with dementia while they are in hospital, The Pharmaceutical Journal can reveal.
“You can bet your boots, families care a lot more about what they’re paying each month for their child’s insulin than impeaching the president." — @ChuckGrassley https://buff.ly/2T23hAv
Trajan Nutrition has signed a memorandum of understanding (MOU) with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by Professors Maria Makrides and Robert Gibson. Trajan Scientific and Medical established Trajan Nutrition in 2017 as a joint venture with Prof Makrides and Prof Gibson. Under t...
The old story of a farmer trying to get a stubborn mule to pull a wagon by dangling a carrot in front of its nose, or hitting its rump with a stick, may not seem to have much to do with the practice of medicine.
SummaryLaboratory water purifier is used to remove impurities, salt ions, bacteria and viruses from water in the laboratory. The processes include capacitive deionization, reverse osmosis, carbon filtering, microfiltration, ultrafiltration, ultraviolet oxidation, or electro deionization.Purified water is a common requirement within all laboratories, particularly research, infection control and pat...
The chaga mushroom-based products market is poised to grow by USD 11.31 billion during 2020-2024, progressing at a CAGR of over 14% during the forecast period. Request free sample pages This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/
A new study published in the journal JAMA Surgery in February 2020 shows that patients with acute appendicitis that were successfully treated either by antibiotics or by appendectomy had identical satisfaction with their treatment and identical quality of life over the long term. The patients who were first treated conservatively and then had appendectomy had lower satisfaction rates.
The marine biotechnology market is poised to grow by USD 2.5 billion during 2020-2024, progressing at a CAGR of over 8% during the forecast period. Request free sample pages This press release features multimedia. View the full release here:
UPM has joined a newly formed Finnish research consortium that plans to use extracellular vesicles to develop novel nano-biotechnological solutions for the early diagnostics and treatment of severe progressive diseases.
– Today, Maven, a women’s and family digital health company, announced it has raised $45 million in Series C funding led by Icon Ventures and including investments from Reese Witherspoon and Natalie Portman. – Maven’s women’s and family telemedicine network expanded rapidly to include 1,700 providers across more than 20 specialties – filling in critical gaps ... Read More
It all comes down to how you define it.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 41st Annual Institutional Investors Conference in Orlando, Fla. on Monday, March 2, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:05 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be av...
Fourth Quarter 2019 Highlights: Total revenue, including royalty and other revenue, was $247.5 million; Product revenue increased 11.8% to $247.4 million, or 12.0% on a constant currency basis; GAAP net income per diluted share was $0.92; and Non-GAAP net income per diluted share was $0.91. Full-Year 2019 Highlights: Total revenue, including royalty and other revenue, was $937.8 mi...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company, today announced plans to participate in the upcoming Cowen Health Care Conference in Boston, Massachusetts. Management is scheduled to present Tuesday, March 3, 2020 at 9:20am ET. Interested parties may access a live and recorded webcast on the “Investors” section of the company’s website at www.pulsebiosciences...